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The classical nucleation theory finds the rate of nucleation proportional to the monomer concentration raised
to the power, which is the ‘critical nucleaus size’, nc. The implicit assumption, that amyloids nucleate in the
same way, has been recently challenged by an alternative two-step mechanism, when the soluble monomers
first form a metastable aggregate (micelle), and then undergo conversion into the conformation rich in β-
strands that are able to form a stable growing nucleus for the protofilament. Here we put together the
elements of extensive knowledge about aggregation and nucleation kinetics, using a specific case of Aβ1−42
amyloidogenic peptide for illustration, to find theoretical expressions for the effective rate of amyloid nucle-
ation. We find that at low monomer concentration in solution, and also at low interaction energy between two
peptide conformations in the micelle, the nucleation occurs via the classical route. At higher monomer concen-
tration, and a range of other interaction parameters between peptides, the two-step ‘aggregation-conversion’
mechanism of nucleation takes over. In this regime, the effective rate of the process can be interpreted as
a power of monomer concentration in a certain range of parameters, however, the exponent is determined
by a complicated interplay of interaction parameters and is not related to the minimum size of the growing
nucleus (which we find to be ∼ 7-8 for Aβ1−42).
INTRODUCTION
Amyloid fibrils are insoluble linear ordered aggregates
of particularly misfolded proteins or peptides, which are
closely connected with neurodegenerative disorders1–4.
As more evidence emerges that oligomers produced at
the early stages of amyloid aggregation could be the most
toxic species5–7, researchers have been keen on under-
standing the details of the nucleation mechanism of fib-
rils, in particular, determining the critical nucleus size
nc of primary nucleation: the minimum size that enables
the extension of amyloid fibrils. Yet, due to the tran-
sient nature of critical nuclei and the low concentration
of nuclei over the whole aggregation time course, there
have been no direct experimental methods of observing
amyloid nucleation process8.
For now, experimental studies monitor the total fib-
ril mass in real time (e.g. by optical experiments10–14),
obtaining kinetic plots with a characteristic sigmoidal
shape15–17. An important quantity, called the lag time
tlag
18,19, can then be extracted; it is defined as the wait-
ing time before a sharp increase of fibril mass appears in
the sigmoidal plot. This lag time approximately holds a
power-law relationship to the initial monomer concentra-
tion C1, as originally suggested by the Oosawa model
20,
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FIG. 1. Key monomeric states of Aβ1−42. The soluble
monomeric state is likely to be the random coil, although the
α-mer from Protein Data Bank (PDB: 1YIT) is also soluble
and only slightly higher in free energy9. The insoluble β-mer
(PDB: 2BEG) is the standard building block of amyloid fibril.
which considers only primary nucleation and irreversible
elongation in aggregation kinetics. Other more advanced
models that further incorporate fragmentation and an-
nealing of filaments18,21,22, all retain this characteristic
relationship. Without secondary nucleation, the power-
law exponent in tlag ∼ Cγ1 is approximately γ = −nc/2,
which then should enables experimental determination
of nc by plotting ln tlag against lnC1 or through a global
fitting scheme of the total fibril mass plots against time
with different initial monomer concentrations as used in
ref.23. However, the validity of such methods of obtaining
the critical nucleus size nc depends on how closely the as-
sumed microscopic aggregation mechanisms and kinetic
equations match the actual ones in experiments.
Before forming an amyloid, monomeric subunits in so-
lution have to switch from their native soluble structure
into a partially unfolded intermediate state, which has
a higher free energy in solution24–26. There are many
possible configurations a soluble peptide can exist in so-
lution: the recent simulation study9 finds the whole hi-
erarchy, from compact conformations rich in α-helix to
a fully unfolded random coil – definitively finding the
random coil having a lower free energy. This challenges
the earlier assumption that the soluble monomer state of
Aβ1−42 is α-helical9,27, see Fig. 1. However, we find it
is sufficient to use a two-state simplification to capture
the essence of amyloid aggregation mechanism, as has
been suggested in molecular simulations28,29: we denote
the soluble monomer as ‘α-mer’ (for its assumed increas-
ing content of α helix when forming micelles), while the
β-mer is the monomeric unit of mature amyloid fibrils.
We later use this two-state simplification to schemati-
cally show two different nucleation mechanisms as an aid
to point out the weakness of previous theoretical kinetic
models on determining the critical nucleus size.
Conventional theoretical models used to find the criti-
cal nucleus size, are usually based on the ‘nucleated poly-
merization’ (NP) concept (see Fig. 2). Other more com-
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FIG. 2. Two mechanisms of amyloid nucleation
plicated models that add secondary nucleation, fragmen-
tation and annealing processes to this NP model18,21,22,
were formulated based on the classical nucleation the-
ory, where the primary nucleation rate is proportional to
Cnc1 , and further assumed a fixed nc value throughout
all monomer concentration regimes. However, already
in 1984, Ferrone has pointed out that the critical nucleus
size nc should change with varied monomer concentration
to account for observations of the sickle hemoglobin poly-
merization rate30. The assumption of a fixed nc value
with varied monomer concentration therefore must be
re-examined.
In recent single-molecule experiments31–34, an alterna-
tive two-step nucleation mechanism has been suggested:
micellation of α-mers (monomers in the native solu-
ble state) followed by a gradual conversion into β-mers
within the dense micelle (Fig. 2). Under this scenario, the
nucleation rate may or may not take the power-law scal-
ing of the initial monomer concentration as would follow
from NP and its derivative models. This may in turn
change the previously predicted power-law relationship
of tlag. Even if the power-law scaling is found to ex-
ist in practice, the physical meaning of its exponent and
its relation to the actual nucleus or micelle size become
unclear. All these questions challenge the validity of em-
ploying these NP models in all monomer concentration
regimes.
Several theoretical works have been proposed for the
two-step nucleation mechanism. The work by Lomakin
et al. in 1997 considered the process of producing crit-
ical nuclei from pre-formed micelles, under the assump-
tion of a fast thermal equilibrium between monomers
and micelles before any nucleation events happen35. A
more recent theoretical framework of two-step mech-
anism (the term ‘nucleation-conversion-polymerization’
model is used there) considered not only nucleation of
micelles but also the step-by-step conversion of this mi-
celle into its fibrillar form36. However, both these studies
make an assumption of a single micelle size, which was
questioned by the observed presence of multi-size micelles
in the coarse-grained molecular simulations of the Aβ1−42
system29. Later, Auer et al. derived theoretical expres-
sions for nucleation rates of both NP and two-step nucle-
ation mechanisms, predicting the monomer concentration
at crossover between these two mechanisms37. However,
it was not clear what is the micelle size that optimizes
the nucleation rate of the two-step mechanism.
The main of our work is to first derive the nucleation
rates, then to estimate the critical nucleus size in the
NP mechanism, and the micelle size that maximizes the
nucleation rate of the two-step mechanism – and finally
compare nucleation rates of NP and two-step mechanisms
to estimate the crossover monomer concentration (similar
to the one in ref.37). In order to fully test the capability
of the two-step model, we deliberately stay with the ba-
sic mechanism, without considering secondary pathways
(secondary nucleation and fragmentation): these are not
expected to contribute significantly at the early nucle-
ation stage.
We choose the free energy approach, originally devel-
oped by Ferrone et al.38, to obtain free energy functions
of intermediate states, final products of amyloid aggre-
gation, and compare the free energy landscape of both
nucleation mechanisms. This not only allows the ana-
lytical calculation of nucleation rates of variable micelle
and nucleus size, but also makes possible a simplified ki-
netic analysis of nucleation rates. Although this generic
scheme of using free energy landscape of nucleation to
find nucleation kinetics is formally similar to the work
by Auer and Kashchiev37,39, our work does investigate
how different micelle sizes can facilitate the conversion
process, which was not addressed before.
Aβ1−42 peptide is used as our model system, since
it has been studied more than any other amyloidogenic
protein; molecular simulations are more reliable due to
its affordable small size, in turn allowing more informa-
tion on thermodynamic parameters to build free energy
functions. However, our model is generic, and only the
binding energy and geometric parameters would differ for
other amyloid systems. For simplicity and clarity of the
main text, many of the derivations, and the justification
of parameter values in our free energy calculation, are
removed to Appendices.
NUCLEATED POLYMERIZATION MODEL
Fibril structures of Aβ1−42 peptides
Within this direct nucleation route, monomeric Aβ1−42
peptides first undergo structural conversion from the α-
state into β-state, and spontaneously stack along one di-
rection to construct a nucleus of a protofilament, or fibrils
with more than one protofilaments (typically this num-
ber lies between 2 to 6)40–44. These fibrils have a twisted
linear structure along the fibril axis, making a complete
pitch every 33 β-mers45–47. Since our aim is to investi-
gate the critical nucleus size, which will be much less than
33 subunits, the twisted fibril structure and its effect on
the later free energy calculations can be neglected.
A cut of the short length in a fibril from the results
of simulation and cryo-electron microscopy further indi-
cated that each protofilament of this fibril was aligned
on the same plane48. To portray a coarse-grained fibril
3structure, it is necessary to further clarify the relative po-
sition of one protofilament with respect to another, when
they are associated together. Although most of the de-
tailed structural studies40,49 are not often resolving this
longitudinal aspect of monomer packing in protofilament
pairs, there are clear indications for the period shift. As
concluded in a computation study of periods of helical
twisting of single and paired protofilaments50, the second
protofilament is shifted by half a period. That is, the lat-
eral monomer binds in the middle between two subunits
of the existing filament, making equal-strength diagonal
bonds with both. Based on these facts, we construct
the coarse-grained structures of single, paired, and mul-
tiple protofilaments, as illustrated in Fig. 3. Two types
of bonds are then involved in these fibril structures: the
end-to-end bond between two β-mers, with a binding en-
ergy ∆β , and the lateral (side) bond for two neighboring
monomers from two different protofilaments, with a bind-
ing energy ∆s each.
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FIG. 3. β-aggregate structure: the number in each β-mer
refers to the order of attachment in the nucleation process.
Double orange sticks represent β bonds, while single orange
ones are side bonds of β-mers.
Free energy functions of fibrils
To construct the free energy of a protofilament, we
use the approach originally used by Ferrone30,38. This
method follows the free energy change of a given species
along the reaction path, relative to the reference state of
pure α-monomers in solution. The formation of an N -
size aggregate is a process where N monomers undergo
an internal transition into β-state, with a conversion free
energy penalty ∆c, and then flock together to form bonds
within the N -size aggregate. In this process, the trans-
lational and rotational free energies of free monomers in
solution are lost, but this loss is offset by the transla-
tional and rotational free energy of an N -size aggregate
as a whole. For simplification, the difference in rota-
tional and standard translational free energies between a
monomer and the N -size aggregate is neglected, as this
difference is of the magnitude lnN with coefficient of 3
kBT only
38, while all other interaction free energies have
a higher dependence on N and with coefficients of tens
of kBT (see Appendix A).
From the bond scheme in Fig. 3, the free energy func-
tion of an N -size aggregate of a single protofilament takes
the following form:
Fβ,1(N) = (1−N)
(
µ0 + kBT lnC1
)
+(N−1)∆β+N∆c.
(1)
Here µ0 is the sum of translational and rotational free
energies of a single α-mer at a standard concentration
of 1 mM. Strictly, µ0 includes many internal rotational
degrees of freedom of a peptide subunit in solution, most
of which become frozen when the monomer adopts the
closely-packed β-sheet configuration in the filament. For
this reason, it is hard to accept any theoretical estimate
for µ0 based on the ideal-gas statistics. Therefore, we
shall use an estimate for µ0 based on experimental mea-
surement of elongation free energy (see Appendix A for
details on all material parameters). The estimate gives
µ0 = −34.5 kBT , for the room temperature T = 25◦C,
and we will use this definition in the remainder of this
work. The initial monomer concentration in solution C1,
in the units of mM (with the reference monomer concen-
tration of 1 mM that we shall use throughout this work).
Values of the free energy of the longitudinal β-bond, and
the conversion free energy in solution are also discussed
in Appendix A: ∆β = −44 kBT 51, and ∆c = 20 kBT 28.
Similarly, the free energy for a paired protofilament
will be:
Fβ,2(N) = (1−N)
(
µ0 + kBT lnC1
)
+Ns(N)∆s +Nβ(N)∆β +N∆c . (2)
Here Ns(N) is the number of lateral (side) bonds in an
N -size protofilament pair: it is zero for N ≤ 2, and we
assume a symmetric Ns = (N − 1) for larger N vales.
The free energy of a side bond ∆s = −22 kBT 52. Finally,
Nβ(N) is the number of longitudinal β-bonds of energy
∆β in a paired protofilament of N -length, which is zero
at N = 1, equal to 1 at N = 2, and then (N − 2) for
other N values (cf. Fig. 3).
It is noticeable that lateral addition of one β-mer to
a pre-formed protofilament would give an interaction en-
ergy of 2∆s: almost exactly the same magnitude as ∆β .
It immediately suggests that lateral addition is equally
likely as addition along the fibril axis, and shall be exper-
imentally observed in fibril formation. This indication is
indirectly supported by the fact that no mature fibrils
have frayed ends in amyloid aggregation, which means
that a protofilament pair is likely to form at the phase
of amyloid nucleation, and is further reinforced by ob-
servations of lateral addition at the early stage of fibril
formation of human amylin43,53.
Obviously, multi-protofilaments will have more
protofilaments joined through lateral addition. To
initiate the growth of an extra protofilament by side
addition of one β-mer to the pre-existing β-aggregate
contributes the binding energy of 2∆s only, which is
weaker than (∆β + ∆s) of an alternative addition of one
β-mer on the fibril end to keep the original protofilament
number. Therefore, multi-protofilament cases will not
have a more favorable bond free energy, and thus the
aggregation free energy would not favor the multi-
protofilament over the paired case at the nucleation
stage. The difference between the protofilament pair
and the multi-protofilament lies in that a larger critical
nucleus and a higher nucleation free energy barrier
4are required for multi-protofilament nucleation. The
presence of multi-protofilament cases in mature Aβ1−42
fibrils is due to other free energy contributions that
originate from the twisted structure of fibrils, and will
become significant as fibrils grow longer. But this effect
does not contribute at the nucleation stage where the
aggregate size is small, and its analysis is outside the
scope of this work. Consequently, multi-protofilament
cases will not be discussed further.
The comparison of free energies of a single and a paired
protofilaments is given in Fig. 4. Due to the increase of
the number of bond sites per monomer addition in the
protofilament pair when N exceeds 3 (one at the end and
the other on the side of the protofilament), the protofila-
ment pair has a lower free energy than a single protofila-
ment with the same number of units. A thermally stable
aggregate is the one that should have a larger population
than monomers, when thermal equilibrium is reached, i.e.
a negative free energy with respect to the reference state
chosen to be α-monomers in solution. Single protofila-
ments cannot be thermally stable and must transform
into protofilament pairs through lateral addition at the
early stage of nucleation. We therefore conclude that
the critical nucleus size is always nc = 3 in the paired
protofilament. The free energy barrier of aggregation in
the NP model is then equal to Fβ,2(3, C1).
The nc value we predict here is not the same as, al-
beit close to nc = 2 obtained by recent experimental
studies of Aβ1−428,54. This inconsistency may be due to
the denaturant used in experiments (i.e. sodium azide)
to initiate amyloid aggregation, which can significantly
change the interactions between monomers, and our in-
teraction parameters do not cover this effect. Kashchiev
and Auer also analyzed the nucleation free energy of β
strands in a 2D nucleus model39, yet they concluded a
variable critical nucleus size, which we do not observe
in the examined concentration regime. In their work,
the nc value starts from a rather large size (over 40 β-
strands) at low concentration, and then shrinks as the
function of 1/(lnC1)
2. In this sense, our result as well
as the experimental work by Knowles54 are likely to fall
within the high concentration/saturation regime, where
further increase in concentration can cause little effect
on the critical nucleus size than at a rather low concen-
tration regime Kashchiev and Auer were interested in.
However, later in this paper we will demonstrate that
the two-step mechanism of nucleation becomes prevalent
at higher monomer concentrations.
Our conclusion that critical nuclei are exclusively in
the form of paired protofilaments is supported by the fact
that only multi-protofilament aggregates are observed at
neutral pH and high ionic concentration43. It is arguable
that our conclusion cannot be applied at low pH and
ionic strength, where single protofilaments do appear43,
because molecular simulations giving bond free energy
parameters, ∆β and ∆s, were only implemented under
neutral pH values so far (and so we do not know the
values of these energy parameters in other situations).
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FIG. 4. Aggregation free energie of a single protofilament and
a protofilament pair, Fβ,1(N,C1) and Fβ,2(N,C1), as func-
tions of the number of aggregated peptides N with three ini-
tial monomer concentrations in solution: C1 =10 mM (solid
lines), 1 mM (dashed) and 1 µM (dotted). The units of the
y-axis are kBT at room temperature.
We shall not worry about this limitation of our model
since it is under physiological conditions, at neutral pH,
that we intend to investigate the problem.
A. Nucleation rate of the NP mechanism
Since the rate-limiting (slow) process is actually the
nucleation itself, while the subsequent elongation is fast,
we could take the rate of producing (nc + 1)-mers,
i.e. tetramers here, as the measure of nucleation rate
in the NP model. We assume the pre-thermal equi-
librium for the population of the critical nucleus size,
C1 exp [−Fβ,2(nc, C1)/kBT ], with nc = 3 here, and then
use the theoretical expression for the elongation rate for
the pre-existing fibril obtained in ref.55.
Two consecutive processes are involved in elongation:
the diffusive arrival of a monomer at the fibril end, and
the attempt to cross an additional free energy barrier to
achieve internal conversion, leading to a frequency fac-
tor: exp (−∆Fel/kBT )/(τD + τI)55, see Appendix B for
derivation. Here ∆Fel is the barrier to overcome in elon-
gation and is roughly 3.42 kBT for Aβ1−42 peptide56,57.
τI is the time-scale for internal α to β rearrangement
of amyloidogenic species (the value of τI is estimated as
10−5 s in Appendix A), while τD is the arrival time to the
fibril end. The rate of producing tetramers, k1C1, is the
product of this frequency factor and the concentration of
trimers:
k1C1 =
C1
τD + τI
e−[Fβ,2(3,C1)+∆Fel]/kBT (3)
The rate constant k1 is interpreted as the nucleation
rate constant for the NP mechanism. The arrival time
τD is the Smoluchowski diffusion rate in solution (as-
suming no crowding effects). Taking into account the
5non-spherical shape of critical nuclei, one can modify
the Smoluchowski theory for bimolecular reaction rate
constants58, as well as the Stokes-Einstein equation for
diffusion coefficients, producing the estimate: 1/τD =
4kBTC1fgeo/3ηr1, where η is the solvent viscosity, r1 is
the hydrodynamic radius of one α-mer in solution. Note
that 4kBTC1/3ηr1 is the classical Smoluchowski result,
modified here by the geometrical factor fgeo that ac-
counts for the shape of the β-aggregate (this geometry
factor makes only a small correction and will not influ-
ence the conclusions we make in this paper). With this
expression for the arrival time, the rate constant of the
NP mechanism, k1 in (3), is expressed as:
k1 =
fgeoC1
fgeoτIC1 + 3ηr1/4kBT
e−[Fβ,2(3,C1)+∆Fel]/kBT (4)
Equation (4) shows that k1 is proportional to C
3
1 when
the monomer concentration C1 is low and the term
fgeoC1τI can be neglected in the denominator (remember
that Fβ,2(3, C1) is proportional to −2 lnC1). In contrast,
when the term fgeoC1τI dominates in the denominator
at high monomer concentration, the rate constant only
has the square of the C1 concentration left: k1 ∝ C21 .
TWO-STEP NUCLEATION MECHANISM
Micellation of soluble peptides
Several experiments have reported that amyloidogenic
proteins or peptides in their native state can coalesce into
a single micelle (some papers may use the term oligomer
in this context) utilizing solvent-exposed hydrophobic
patches on the surface of monomers59–62. For example,
taking lysozymes (a type of amyloidogenic proteins), mi-
celles have a lower content of α-helix and a higher content
of β-sheet yet with the majority being disordered loops
compared with native monomeric units62. Therefore, ag-
gregated micelles are often classified as amorphous. It is
suggested that these amorphous micelles serve as inter-
mediates, or initiation states for amyloid nucleation63.
This generic hypothesis of the role of micelles is indi-
rectly hinted by the increase in β-sheet structural content
while losing their original α-helix content62, and is fur-
ther supported by molecular simulation of coarse-grained
peptides29,64. These facts imply an alternative aggrega-
tion pathway for amyloid fibrils: the two-step nucleation
mechanism as described in Fig. 2.
In our work, micelles are defined as composed of a
few α-mers aggregated from solution. Though micelles
could have a variety of structures65, we will assume them
to be amorphous globular aggregates of densely packed
monomers for simplicity. The driving force for micel-
lation of Aβ1−42 peptides originates mainly from hy-
drophobic interaction between α-mers29,66. We define
one α-bond as the bond formed between a pair of α-
mers inside a micelle. The total number of such α bonds,
Nα(N), for a spherical N -size micelle can be assumed to
have the bulk and surface terms. Since the expression
Nα(N) has to reduce to Nα(2) = 1, it is easy to ob-
tain: Nα(N) = AN + (1 − 2A)2−2/3N2/3, with just one
unknown parameter A.
With only hydrophobic attraction accounted for, an in-
finite micelle size could be expected in equilibrium. How-
ever, aggregation is constrained by other unfavorable free
energy factors, e.g. the electrostatic repulsion due to ac-
cumulation of negative charge on the surface67, and the
entropic loss from the compact packing of several α-mers
into a micelle68. Therefore, a large micelle size is never
observed in experiment.
A crude but convenient way to estimate the electro-
static repulsion is to assume that electrostatic charges
distribute evenly on the spherical surface of the packed
micelle. Then the repulsion energy is (Nqe)
2/8pi0rN
69,
where qe is the effective charge on a single α-mer,  and
0 are the relative dielectric constant and the permittiv-
ity in vacuum, rN is the radius of the N -size micelle,
proportional to N1/3 if we assume it is roughly spheri-
cal. Accordingly, the electrostatic potential energy has
the overall scaling of N5/3.
The screening effect from counter ions in solution
may challenge the validity of using the expression
(Nqe)
2/8pi0rN for the potential energy of electrostatic
repulsion. However, this Debye screening effect requires
mobile charges in thermal motion. Without a doubt
it would exist between any two charged micelles or
monomers in solution. Yet the potential energy quoted
above refers to the energy to confine charges in a small
volume when starting from a well-separated distance (i.e.
the interaction of immobile surface charges across the
packed micelle itself). In this case, no counter charges
exist inside micelles, and even if there were some, they
would have very little mobility due to the compactness of
internal structure. Therefore, the Debye screening effect
cannot play a role. This enables the use of electrostatic
potential in an effective dielectric medium in our case.
In addition, there is an entropic cost of forcing po-
lar amino acid groups to the micelle surface, an ef-
fect well-studied in the formation of micelles of polar
surfactants68. The simplest expression of the free en-
ergy expressing this reduction in conformational freedom
turns out to scale as N5/3, in an analogy to the electro-
static repulsive energy of a sphere with evenly distributed
surface charge70. Although the actual entropic repulsion
term can be of more complex forms, this N5/3 scaling can
be the leading term, and helps to correctly predict the ex-
perimentally determined concentration threshold where
monomers starts aggregating into micelles68. Therefore,
we account for these two repulsive free energy contribu-
tions (electrostatic and entropic) as a single term hN5/3,
with its parameter h to be determined.
Assembling together the free energy of α bonds and the
repulsive free energy terms, the micellation free energy,
6Fmic(N,C1), can be written as:
Fmic(N,C1) =(1−N)
(
µ0 + kBT lnC1
)
+ hN5/3
+ ∆α
[
AN + (1− 2A)2−2/3N2/3
]
(5)
Note a close resemblance of this expression, and Eqs.
(1) and (2) for protofilaments. Here the important pa-
rameter is ∆α, the free energy of an attractive α-bond,
which is approximately −17kBT estimated from the work
of Hills and Brooks71 (see Appendix A). Fmic(N,C1) is
analogous to free energy of micelle formation in surfac-
tant solutions, or flocculation in colloids. At a certain
threshold monomer concentration, monomers and mi-
celles of a specific size are equally favored at thermal equi-
librium; this is the ‘critical micelle concentration’ (cmc),
and the corresponding micelle size is the ‘critical micelle
size’ (cms). In fact, the presence of the critical micelles
in the Aβ peptide system with different solvents and pH
values has been already reported35,72–74.
The micellation free energy, Fmic(N,C1), and the slope
of Fmic(N,C1), are both zero at N = cms, as in any coex-
isting equilibrium. These two independent conditions let
us evaluate the parameters A and h from experimentally
determined values of cmc = 17.6 µM, and cms = 25,
which were measured in the solvent system that more
closely reproduces the physiological conditions61. In this
way we obtain the parameters to be used in the rest of
this work: A = 4.86 (dimensionless) and h = 1.6 kBT .
Both values make good physical sense, although we shall
not spend any more time on this discussion.
We can now plot Fmic(N,C1), at cmc and several other
values of monomer concentration, in Fig. 5. At low
monomer concentrations (below approximately 1 µM for
our chosen set of parameters), Fmic(N,C1) is a monotoni-
cally increasing function ofN , and no metastable micelles
can exist. This threshold concentration can be easily de-
rived from (5). It is therefore impossible to have the
two-step nucleation mechanism for amyloid aggregation
below 1 µM in the Aβ1−42 system. When monomer con-
centration exceeds 1 µM, Fmic(N,C1) has a metastable
state, and a free energy barrier to cross to reach a micelle.
We define the micelle size that gives the barrier position
as Nh, and the size that sits at the lowest point of the free
energy trap as Nl, both labelled in Fig. 5. Only micelles
with the size between Nh and Nl are metastable and can
follow the two-step nucleation mechanism. Since the bar-
rier occurs at relatively low N , the stabilizing effect of the
electrostatic h-term is not yet important and we can find
an approximate expression for the barrier position, useful
in the subsequent analysis (Nh varies between ∼ 4.5 at
the lowest C1 end, to ∼ 2 at the highest):
Nh ≈ 2
27
(
(2A− 1)∆α/kBT
A∆α/kBT − µ0/kBT − lnC1
)3
.
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FIG. 5. Micellation free energy Fmic(N,C1) (in units of kBT
at room temperature) vs. the micelle size N . From top to
bottom: C1 lower than the threshold monomer concentration
to have metastable micelles (0.5 µM), C1 = cmc (17.6 µM),
and C1 well above cmc (50 µM). Nh and Nl are the local
maximum and minimum of Fmic(N,C1), respectively.
Conversion of micelles
Based on two structural facts about fibrils, we can as-
sume that α-β conversion happens on the surface of the
remaining α-mers in the packed micells as schematically
illustrated in Fig. 2. Firstly, due to the twisted struc-
ture of β-aggregates, it would cost more free energy to
twist inside a dense amorphous micelle than being uncon-
strained on the surface of this micelle47. Besides, α-mers
interact with the pre-formed β-aggregate mainly at the
end of the emerging fibril. This is because the region of
exposed hydrophobic groups designed to attach to the β-
aggregate is on the end of a β-stack. Accordingly, α-mers
tend to gather near the end area of the fibril to gain more
interaction energy.
We choose x ∈ (0, N), the number of converted α-
mers, as the reaction coordinate in the micelle of size N .
The free energy along the conversion path, Fc(N, x,C1),
is composed of four contributions: the free energy of a
remaining (N − x)-size micelle, Eq. (5); the free energy
of the emerging x-size β-aggregate, Eq. (2); the bonding
free energy of an interface between the micelle and the
aggregate, which will be detailed later; and an additional
free energy loss of −(µ◦+kBT lnC1) in translational and
rotational motions, which is to compensate for one degree
of center-of-mass freedom that is present in separate ex-
pressions for the α-micelle and the β-aggregate, but is
removed when they are bound and move as one entity.
Organizing these separate terms, the conversion free en-
ergy Fc(N, x,C1) takes the form:
Fc(N, x,C1) = (1−N) (µ◦ + kBT lnC1) + h(N − x)5/3
+ ∆αNα + ∆αβNαβ(N, x)
+ x∆c + ∆sNs(x) + ∆βNβ(x) , (6)
where Nα = A(N − x) + (1 − 2A)2−2/3(N − x)2/3 for
the remaining micelle, and ∆αβ is the free energy per αβ
7bond, which is defined as the bond formed between an
α-mer and a β-mer. This is a parameter we know the
least about; the range of reasonable ∆αβ values is given
in Appendix A. We now proceed to find the expression
for Nαβ(N, x), the number of total αβ bonds in this in-
termediate aggregate.
Under the assumption that αβ bonds originate from
the replacement of pre-existing α bonds, and that the
emerging β-aggregate is located on the surface of the
micelle, we can compare two expressions for Nα – one
including the β-mers at the contact interface as yet non-
converted α-mers, and the other with an actual remaining
(N − x) α-mers. The resulting expression is a non-linear
function of N due to the surface term present in the def-
inition of Nα. When x is smaller than 3 (giving only a
single protofilament geometry), the number of αβ bonds
is Nαβ(N, x) = Nα(N − x + 1) − Nα(N − x). On the
other hand, when x ≥ 3 (paired protofilament starting to
form), Nαβ = Nα(N −x+ 2)−Nα(N −x)−1, where the
additional −1 is due to the replacement of one original α
bond with the β bond that bridges two protofilaments on
the micelle surface instead of contributing to Nαβ(N−x).
In Fig. 6 we examine the conversion free energy of a
hexamer (N = 6) as an illustration of two key features of
free energy evolution during conversion: the ‘peak’ and
the trap in Fc(N, x). The peak of the conversion free en-
ergy is always at x = 2 no matter how strong the coupling
∆αβ is. This is a generic characteristic for the micelle size
larger than 4 due to the presence of the second protofila-
ment at x = 3, almost doubling the number of αβ bonds
and causing an enormous stabilizing effect to drag down
the value of Fc. A local free energy minimum, which we
call a ‘trap’ could exist, just before this barrier, at x = 1
(a minimum appears at ∆αβ = −22 kBT , in Fig. 6). The
difference Nαβ(N, 2) − Nαβ(N, 1) is negative, while the
difference in Nαβ is positive between x = 1 and x = 0;
this assures that the trap can only be at x = 1. It should
be noted that even though the local minimum appears
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FIG. 6. Free energy of conversion Fc of a hexamer (N =
6) at monomer concentration of 1 mM, as a function of the
conversion fraction x, for three ∆αβ values: −18 (solid line),
−20 (dashed) and −22 (dotted) (in units of kBT ). ∆Fc is the
conversion barrier. The peak of Fc occurs at x = 2, while the
‘trap’, if present, is at x = 1.
only at ∆αβ = −22 kBT in the hexamer case of Fig. 6, it
can be present at other ∆αβ values with a larger micelle
size, when the value of Nαβ(N, 1) − Nαβ(N, 0) and the
negative value of the difference Fc(N, 1, C1)−Fc(N, 0, C1)
increase.
The conversion barrier for an N -size micelle, ∆Fc, is
defined as the free energy difference between the peak
and the minimum (the trap or x = 0) along the reaction
coordinate of conversion. In other words, the barrier ∆Fc
is evaluated either as the difference Fc(N, 2)− Fc(N, 0),
or instead as Fc(N, 2)− Fc(N, 1) when a trap is present,
as eventually always happens at a sufficiently large N .
As a result, ∆Fc is not a simple single-valued function.
Nucleation rate of the two-step nucleation mechanism
Each individual nucleation path in the two-step mech-
anism is characterized by the final size N of the micelle
that forms along the pathway. The nucleation free energy
landscape is plotted with combined Fmic and Fc. For the
micelle size between Nh and Nl (see Fig. 5), the nucle-
ation free energy landscape has two barriers: one for the
micellation formation and the other for the α-β conver-
sion with a metastable (intermediate) state in between.
This pathway is illustrated in Fig. 7 for the case of a hex-
amer micelle (N = 6) and C1 = 1 mM. The plot starts
with the expression for the micelle free energy Fmic(N),
which passes over the micelle nucleation barrier Nh ≈ 3
and then starts decreasing towards the micelle minimum
(which for this concentration will be an Nl = 35). How-
ever, at the micelle size N = 6 the conversion starts,
and the remaining part of the plot gives the free energy
Fc(6, x). This part is not a continuous but a piece-wise
function of x, same as in Fig. 6, because the expressions
for the bond counts Ns, Nβ , and Nαβ are all piecewise.
This, however, does not affect the conclusions on the bar-
rier height or kinetic parameters calculated below. This
overall free energy profile allows the use of a three-state
kinetic model.
Several ways can be used to approach this three-
state kinetics problem, a most direct being the applica-
tion of the general Kramers-style analysis of steady-state
flux75,76. However, even a simpler problem, with just
one variable (degree of freedom) and a potential with
two maxima surrounding the intermediate state, cannot
be solved analytically except in limiting cases when one
barrier is much higher than the other. In this work, this
is further complicated by the fact that we have two sepa-
rate variables, N for the micelle size and x for the degree
of conversion, and in most cases the free energy barriers
in Fig. 7 are not high, when viewed from the interme-
diate state. Therefore, no formal analytical solution is
anticipated in this diffusion-type scheme.
Instead, we choose a different method of evaluating
the overall nucleation rate. We separate the nucleation
process into three distinct elements: the transition rate
of association from the monomer into the intermediate
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FIG. 7. Nucleation free energy landscape of an example hex-
amer (N = 6) for C1 = 1 mM. Note the composite nature of
the x-axis: The left half of the plot is in the reaction coordi-
nate for micellation, N , and the free energy function here is
Fmic(N). The right half is plotted along the conversion coor-
dinate, x, and producing Fc(x) values. Two barriers(∆Fmic
and ∆Fc) and three key states are labelled in the plot. Fm
is the free energy of the intermediates (in this example: the
N = 6 micelle before conversion).
state (written as k+C1), the reverse transition rate of
dissociation from the intermediates back to monomers
(as k−Cint), and the transition rate of conversion from
the intermediate state into the final β-aggregate state
(kcCint), where Cint is the concentration of micelles (the
intermediate species). Then we derive the effective nucle-
ation rate from monomers to the final aggregate, defined
as k2C1, and its rate constant k2.
Strictly, there has to be a reverse process from β-
aggregate back to the intermediate micelle state, and also
a process of explosive instant dissociation of β-aggregate
into monomers. These two processes are necessary if
one is to find an equilibrium steady-state solution to this
problem. However, our interest is to study the amyloid
nucleation from solution, which is a very non-equilibrium
process: the first stage of a fibril growth process leading
to much lower free energy states where one would need to
investigate the possible equilibration22. Besides, the sub-
sequent elongation of the aggregate larger than the criti-
cal nucleus size is usually rather rapid, and therefore the
reverse conversion from the final aggregate state back to
the metastable state is slow and can be ignored. Conse-
quently, we ignore the two very low-probability processes
and regard the final β-aggregate state as irreversible.
We use a strategy similar to the probabilistic single-
molecular approach by King and Altman tackling the
Michaelis-Menten enzymatic reaction77. Evaluation of
the average time to reach the final state of nucleation,
made up of an infinite number of paths with varied
times of repeated micellation and dissociation processes,
gives the effective nucleation rate constant in one two-
step mechanism path, k2 is expressed as follows (see Ap-
pendix C for derivation):
k2 =
k+kc
2k+ + k− + kc
(7)
Although this effective rate constant k2 is slightly dif-
ferent from the traditionally used expression (see ref.78
for instance), Eq. (7) recovers the average rate constant
of the steady-state approximation, where the assump-
tion that kc + k−  k+ is used, giving the more fa-
miliar expression: k2 = k+kc/(kc + k−). Two limiting
cases further validate Eq. (7). When kc  k−, k+, then
the rate limiting process is the micelle formation, and
k2 = k+. This result is reasonable since the metastable
species quickly converts into the aggregate. The other
limiting case is when k−  k+, kc. In this case k2 =
k+(kc/k−) k+, which reflects the alternating between
the monomeric and intermediate states: completion of
the reaction becomes a rare event. Both are also limiting
cases of the steady-state kinetics.
We now proceed to find explicit expressions for the
rate constants k+, k− and kc. A convenient way to es-
timate the micellation rate of N monomers is to sep-
arate the formation of an N -size micelle into the for-
mation of one (N − 1)-size pre-micelle followed by one
α-mer attachment. In this scheme, we use the Smolu-
chowski rate of forming a spherical micelle of size N :
4piDm(r1 + rN−1)CN−1C1, where Dm is the mutual dif-
fusion coefficient, CN−1 the concentration of (N−1)-size
micelles, and r1 and rN−1 the radii of one monomer and
an (N−1)-size micelle79. To form an (N−1)-size micelle,
there is a free energy barrier ∆Fmic to cross, since (N−1)
is always larger than Nh in the three-state kinetic model.
To find the concentration CN−1, we separate it into two
parts: a pre-thermal equilibrium concentration of Nh-
size micelles is first assumed to be reached, and then the
simultaneous adsorption of (N − Nh − 1) monomers to
this pre-micelle takes place, which is assumed to act as
a deep adsorbing sink (see Appendix D for derivation).
Assembling the terms, k+ takes the form:
k+ = ω+e
−∆Fmic/kBT , (8)
where ω+ =
2kBT
3η
CN−Nh1
(
2 + 3
√
N − 1 + 1
3
√
N − 1
)
·
[
4pir31
3
(1 + 3
√
Nh)
3
]N−Nh−1
.
From Eq. (5), it is clear that e−∆Fmic/kBT is proportional
to CNh−11 . Consequently, the product k+C1 implicitly
has the factor CN1 in it, and therefore corresponds to
the kinetic expression for the N -particle collision, which
validates our formulation for the constant k+.
In a system where the monomer concentration is main-
tained constant (either by re-supplying the depleted
molecules from a reservoir, or simply ignoring the small
change at the nucleation stage), the micelle dissociation
rate constant k− can be derived from an argument based
on the thermal equilibrium condition that requires the
9dissociation rate equal to the micellation rate, namely
the equation k− = k+ exp(Fm/kBT ). The expression for
k− is then:
k− = ω+e−[∆Fmic−Fm]/kBT . (9)
Here Fm is the free energy of the metastable state: the
micelle of size N , see Fig. 7. The expression for Fm
has the term of (1 − N)kBT lnC1 arising from Eqs.
(5) or (6), and therefore the product of CN−Nh1 in ω+
and exp[−(∆Fmic−Fm)/kBT ] does not have the explicit
power-law dependence on C1. The rate constant k− de-
pends on C1 only implicitly, and weakly, through Nh that
appears in ∆Fmic. At a fixed monomer concentration, an
increase in N decreases the value of k− by having a larger
negative α and αβ bond free energies in ∆Fmic − Fm,
which results in a smaller probability to break all the
bonds into monomers.
The rate constant of the conversion reaction kc is found
directly from the Kramers escape theory, and is the prod-
uct of the activation factor over the barrier ∆Fc and the
attempt frequency from thermal fluctuations of positions
of the Aβ1−42 segments, 1/τI , which has first appeared
in the derivation of k1, Eq. (3):
kc =
1
τI
e−∆Fc/kBT (10)
With the three rate constants determined, we can write
down the overall rate of amyloid nucleation k2 for a
given size N . The full expression is cumbersome, but
let us examine k2 in two limiting cases. One is k2 ≈ k+
when kc  k−, k+ (micelle formation from solution is
the rate-limiting process); the other is k2 ≈ k+(kc/k−)
when k−  k+ and kc (conversion of a micelle is the
rate-limiting process). These two extreme cases give the
expressions of ω+e
−∆Fmic/kBT and e−(Fm+∆Fc)/kBT /τI ,
respectively. When conversion is the major barrier, k2
depends on the highest free energy, i.e. Fm + ∆Fc, cf.
Fig. 7, and is the product of a quasiequilibrium popula-
tion for the metastable state and the probability to cross
the conversion barrier. On the other hand, when the mi-
cellation process is slow, k2 depends on the ∆Fmic barrier
only. In general, Eq. (7) is a mixture of these three ki-
netic processes.
The fastest growing nuclei
Since the monomer concentration in experiments
mostly is within the range from µM to a few mM, and
using the standard concentration of 1 mM, we let lnC1
vary from −6.5 (i.e. C1 ≈ 1.5µM, approximately the
threshold monomer concentration to initiate the two-step
mechanism, discussed in the section of micellation of sol-
uble peptides, Fig. 5), up to lnC1 = 2 (corresponding
to C1 ≈ 7.4 mM). Values of C1 outside of this common
experimental range will not be discussed further. From
Eqs. (4) and (7)-(10), we evaluate ln (k2/k
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FIG. 8. Plots of ln k2 (normalized between 0 and 1) against
the micelle size N for several C1 values (using an example of
∆αβ = −18 kBT ). The N -axis range in each plot is between
Nh(C1) and Nl(C1), where the relevant range of two-step nu-
cleation occurs. The width of each peak is indicated in the
plots.
micelle sizes at several monomer concentrations, where
the reference rate constant k◦1 is the value of the rate k1
of the NP mechanism at lnC1 = −6.5, referring to the
lowest monomer concentration case we investigate. In
this way, the fastest rate of two-step nucleation can be
detected, identifying the dominant micelle species N∗ in
this nucleation mechanism.
The x-axis in the ln k2 plot varies from Nh to Nl, which
is the range of the metastable micelle sizes that can adopt
the two-step mechanism for each chosen monomer con-
centration C1. For clarity and convenience, we normalize
the plots of ln k2 to extend between 0 and 1. The width
of the peak of nucleation rate, if such a peak exists, is
defined as the size range of micelles with the fraction
of 0.5 in the y-axis. All the parameters involved in the
estimation of k2 have been listed in Appendix A with
the room temperature for T and the viscosity of water
at room temperature for η. The results for ln k2(N), at
∆αβ = −18 kBT as an illustrative example, are shown in
Fig. 8. The plots in Fig. 8 show two main features: the
peak of the nucleation rate that occurs at a certain mi-
celle size N∗(C1), and the width of this peak increasing
as the monomer concentration increases.
To understand the fastest growing rate, let us exam-
ine the contributing effects of micelle formation at a rate
k+, and its conversion at a rate kc. For the parameters
corresponding to Aβ1−42 (Appendix A), the conversion
barrier ∆Fc is always between 10 and 25 kBT for the
micelle size below 40 (which is clearly the maximum mi-
celle size value that we will encounter). On the other
hand, the barrier to form a micelle, ∆Fmic, starts from
roughly 50 kBT at lnC1 = −6.5, and decreases to 20
kBT at lnC1 = 2, meaning that the rate k+ at N = Nh
is very small – and then sharply increases as C1 grows
to finally become comparable with kc at high concentra-
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tions. The value of k− at N = Nh is very high, which is
easy to see by inserting Fm = ∆Fmic at N = Nh in Eq.
(9). Then k− decreases dramatically as N grows from
Nh, due to the C
N
1 e
Fm/kBT factor in (9). Hence there
must exist a particular micelle size N∗ when k− ≈ kc.
When N < N∗, we have the nucleation rate constant
k2 ≈ kck+/k− = kce−Fm/kBT , which a is growing func-
tion of N . On the other side, at N > N∗, the k− is
small and k2 ≈ k+, which is a decreasing function of
N . Between these regimes we will always find the point
N = N∗ of the fastest rate of two-step nucleation.
To put it more physically, when micelle size is too
small, it suffers a rather large dissociation rate and can-
not undergo the full subsequent conversion into fibrils.
As micelle size grows bigger, they become less prone to
dissociation and will have adequate time to complete con-
version process. However, a further growth of micelles
will decrease the micellation rate. In this case, micella-
tion is the rate-limiting process and the total time of the
two-step nucleation will therefore increase with micelle
size. Basically, this N∗ value is the size where the effect
of slow micellation process starts to take over other two
kinetic processes.
Figure 9 illustrates this effective size of the critical nu-
cleus N∗ (the ‘peak’ in Fig. 8) against the monomer con-
centration C1, using three values of the α-β interaction
parameter ∆αβ from its plausible range. At very low
monomer concentrations, this nucleation size N∗ starts
from a larger value, gradually decreasing to finally reach
a plateau that spans over a broad range of concentra-
tions. (There is an additional feature: the re-increase
of N∗ for a low ∆αβ = −18 kBT at very high concen-
trations, which we do not fully understand and will not
be discussing further). These values of ‘critical nucleus’
size are within the range obtained by the coarse-grained
molecular simulations of Saric´ et al.29: from 2 to 14;
they also fall within the experimentally observed values
(2 to roughly 25)80. Notably, the fact that N∗ is not
a constant value in Fig. 9 indicates the weakness of the
assumption about a fixed, concentration-independent mi-
celle size before conversion, which was employed in the
previous two-step kinetic model36. Nevertheless, a typi-
cal prediction of the critical nucleus size N∗ ' 7-8 over
a broad range of monomer concentrations seems to be
appropriate. We believe this N∗ value is reasonable, and
is close to the previous work of the two-step nucleation
kinetics of amyloid peptides by Lomakin et al.35, which
gave the nucleus size of 10, although they did not con-
sider the conversion process from micelles into fibrils.
To qualitatively understand the dependence of N∗ on
concentration C1, we can use the approximate condi-
tion for the peak of the total rate constant k2, namely
k− ≈ kc, where we take kc to be a constant (it has only a
slow variation with N compared with k−). From Eq. (9)
we know that k− does not have a power-law dependence
on C1, and we further ignore the electrostatic/entropic
repulsion term in Fmic since the micelle size is quite small
and this repulsion free energy is relatively low in this re-
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FIG. 9. The plot of the fastest-growing nucleus size N∗
against lnC1, for three values of ∆αβ/kBT : −18 (dotted line,
circles), −20 (dashed line, squares) and −22 (solid line, dia-
monds) from top to bottom. We conclude that a safe assump-
tion is that N∗ ≈ 7 for Aβ1−42, for a broad range of monomer
concentrations.
gion. The difference N − Nh, required for this ratio to
reach a constant value, depends on the choice of Nh due
to the nonlinear term in Nα. A small Nh requires a
larger difference compared with higher Nh values. One
should further notice that Nh depends on C1 and grad-
ually decreases as C1 increases (see Fig. 5). Therefore,
N∗ is controlled by two opposite effects: the shift of Nh
to a lower value with an increased lnC1, and the growing
N − Nh difference required for ln k− to reach a specific
constant as lnC1 increases. At a small C1, the shift of Nh
wins, causing a larger N∗ value. As C1 increases, these
two effects may offset each other, explaining the plateau
region in Fig. 9. The re-increase of the N∗ value with
∆αβ = −18kBT at lnC1 ≥ 2 is likely due to the other
peak condition, that k+ ≈ kc. At such a high C1, the mi-
celle formation rate k+ decreases slowly with N , which
allows the micelle sizeN to grow more significantly before
k+ reaches the required kc value, producing a noticeable
increase in N∗.
Strictly, the total nucleation rate in the two-step mech-
anism, k
′
2 is the sum of all k2 values of different individ-
ual pathways labelled by the micelle size N , at a given
monomer concentration C1. However, due to the pres-
ence of the sharp peak in k2(N), we may ignore the
spread of different nucleus sizes and only represent nucle-
ation by the peak rate k2(N
∗). A comparison of these two
values is given in the inset of Fig. 10, proving that the er-
ror in ignoring nucleation pathways other than N∗ is very
small. This allows us to investigate how k∗2 changes with
increasing monomer concentration, and propose possible
explanations for the features present in Fig. 10.
COMPARISON OF NUCLEATION RATES
With Eqs. (4) and (7), a comparison of rate constants
of the two competing mechanisms, k1(C1) and k2(C1), is
plotted in Fig. 10. Both rate constants are normalized by
the same factor: the k1 value at lnC1 = −6.5, referring
11
to the lowest monomer concentration case we investigate.
The ln k1 curve is not perfectly linear on the log-log plot
of Fig. 10 due to the two-competing time-scales in (4).
For the concentration regime we investigate, the diffusive
arrival time τD, which is proportional to C1, is smaller
than the internal re-arrangement time of peptides, τI .
The τD factor is hence screened off, giving roughly a de-
pendence k1 ∝ C21 in Eq. (4). However, in a traditional
approach to nucleation, with the critical nucleus size in
the NP mechanism at nc = 4 (since we used the rate of
producing tetramers as the measure for our nucleation
rate), one expects a cubic dependence: k1 ∝ CNc1 ; this
will be observed when the diffusion time is dominant –
but not in the relevant concentration regime.
For the three versions of k2, for three values of the
conversion penalty ∆αβ , there are two features to ob-
serve. First, a linear trend line could be used to fit ln k2
in the range of lnC1 between -6.5 and 0, which suggests
an effective power-law dependence k2 ∝ Cn1 . However,
the exponent of this power law does not match the value
of the critical nucleus size for the two-step mechanism,
N∗ ≈ 7. Moreover, this slope is not universal and clearly
varies with the values of ∆αβ parameter.
We first focus on how ∆αβ comes into play. At low
monomer concentration, we found that k2 is first deter-
mined by the relation k2 = k+kc/k−, which then changes
to k2 = k+ (the crossover at k− = kc is what determines
the fastest growing size N∗). Accordingly, an increase in
∆αβ has a strong effect on the rate k2 by decreasing the
conversion rate kc at low C1. In contrast, at higher C1 we
have k2 = k+ which does not depend on ∆αβ : different
k2 lines overlapping in the high-concentration regime in
Fig. 10.
The crossover concentration when the two-step mecha-
nism starts to overtake the direct NP mechanism of amy-
loid nucleation is also strongly dependent on the α-β in-
teraction energy ∆αβ , which is why it is important to
have better estimates of its value. But in all cases this
happens in the low- to medium-concentration regime.
From Fig. 10, we find that the two-step mechanism takes
over from lnC1 = −6 (2.5 µM) for ∆αβ = −22 kBT ,
this crossover concentration increasing to lnC1 = −3 (50
µM) for a lower bound ∆αβ = −18 kBT . The crossover
concentration was given as approximately 8 µM by Auer
et al.37, where the two-step mechanism was also con-
cluded to take place at a higher concentration than the
NP mechanism.
CONCLUSIONS
We elucidate the kinetics of two alternative amyloid
nucleation mechanisms, the direct (NP) nucleation and
the two-step nucleation via an aggregation of α-micelle
and its subsequent conversion into the β filament. We
used an equilibrium free energy approach to consider the
possibilities that the critical nucleus and favorable micelle
size change with monomer concentration. This analysis
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FIG. 10. The log-log plot of the normalized effective nucle-
ation rate in the two-step mechanism, ln k2, and in the NP
mechanism, ln k1, against the monomer concentration C1, at
three values of ∆αβ = −18 (dotted line), −20 (dashed line)
and −22 (solid line). The lines are fitted linear trends of ln k2,
whose slopes are given as approximately 5.9 (black), 5.3 (blue)
and 4.8 (red). The bold solid line of ln k1 is not perfectly lin-
ear, but has the slope exponent of approximately 2 at higher
C1. For comparison, we show the slopes of C
7
1 and C
3
1 , where
the exponents are the critical nucleus sizes in the two mecha-
nisms. The inset shows the comparison of the total rate ln k
′
2
(squares) and the peak rate ln k∗2 (lines), demonstrating that
the difference is very small.
of the composite free energy landscape in the two-step
mechanism allows the use of a simplified three-state ki-
netic model and thus the analytical derivation of the ef-
fective nucleation rate constant. We define the critical
nucleation size by the fastest growing rate criterion, hav-
ing verified that this rate dominates a practically mea-
sured total rate of nucleation.
We find that theoretically predicted variation of nucle-
ation rate with monomer concentration could be easily
interpreted as a power law in the analysis of experimen-
tal data, even though the actual expression is not. For
the NP mechanism, the critical nucleus size is determined
to be the trimer of the protofilament pair, and this does
not change within the monomer concentration range we
investigate. On the other hand, in the two-step mecha-
nism, the micelle size with the largest nucleation rate is
dependent not only on monomer concentration, but also
on the strength of the interaction between α- and β-mers
(∆αβ). Generally speaking, the optimized micelle size
decreases from around 10 to around 7, and then remains
at this value for a wide concentration range, pointing out
the inappropriateness of the pre-assumption of the fixed
micelle size in the previous kinetic approaches.
Although a nearly power-law relationship of both nu-
cleation rates on monomer concentration is observed, the
exponent of the ‘apparent power law’ in the two-step
mechanism have no simple relationship on the critical
nucleus size, as would be expected from the kinetic for-
malism of classical nucleation theory. The exponent of
k2 ∝ Cn1 also depend on ∆αβ , and is determined by a
complex interplay between micellation, conversion and
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dissociation processes. Unfortunately, such complexity
makes the rigorous analysis of these effective power laws
hard to carry out. But it is certain that the critical nu-
cleus size obtained by fitting the Oosawa model, or other
kinetic models that all assume the classical nucleation
formula in amyloid aggregation is not actually the real
critical nucleus size. One may think of some direct ex-
perimental methods of determining the critical nucleus
size that could extract this important nucleation size (in
both mechanisms), and thus compare with our theoreti-
cal predictions. Unfortunately, no such experiments are
yet available, and instead molecular simulations would
be a more plausible way to understand the amyloid nu-
cleation.
It is also important that the theoretical prediction for
the crossover point of concentration where the two-step
mechanism takes over from the direct filament nucleation
depends on the strength of a not well-known interaction
strength ∆αβ . Experiment or simulation are also needed
to focus on finding a more accurate value of this param-
eter, in order for our predictions to become more quan-
titative.
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Appendix A: Values of Aβ1−42 parameters
The values of all parameters are summarized in the
Table 1. An approximate value of ∆c is suggested to
be approximately 20 kBT (T refers to the room tem-
perature 25 ◦C) in the practice of coarse-grained molec-
ular simulations28. It has to be noted that this value
is not a reliable result of rigorous all-atom simulations,
as one would have wished and as is the case for many
other energy parameters we use. In the coarse-grained
simulation28 the authors merely assumed this value to
be reasonable, based on the fact that single β-mers are
not spontaneously formed in solution.
All-atom simulations were carried out to investigate
the interactions between two protofilaments in the model
of Aβ17−42, which is the fraction of peptide sequence
from the 17th to the 42nd amino acid residues of the
native Aβ1−42, and is believed to be the main cause of
the universal structural motif in Aβ17−42 fibrils. This re-
sult suggested a steric zipper formed on the interface of
two protofilaments81. Thus, the ∆s value can be roughly
estimated to be -22 kBT , the typical interaction free en-
ergy of a steric zipper52.
To estimate the value of µ◦, we connect the theoret-
ical elongation free energy formula, namely ∆β + ∆s −
µ◦+ ∆c + kBT ln (C1/C◦1 ) from (2), with the experimen-
tally measured magnitude of elongation free energy of
fibrils. Although this experimentally measured vlaue for
Aβ1−42is not available, a similar (shorter) amyloidogenic
peptide, Aβ1−40, was used to measure its elongation free
energy through evaluating the monomer concentration
in thermal equilibrium with its fibrils82. The result has
produced a value -11.6 kBT in the Aβ1−40 system. We
shall assume that Aβ1−42 should resemble it closely, and
have roughly the same elongation free energy. By insert-
ing ∆β of -44 kBT , ∆s of -22 kBT , ∆c of 20 kBT , and
the elongation free energy of -11.6 kBT in the theoretical
elongation free energy formula, µ◦ is evaluated as -34.5
kBT .
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The value of ∆α cannot be determined from experi-
ments and can only be investigated by molecular simula-
tions. Nevertheless, different results have been obtained
depending on the constraints on the conformation of pep-
tides that are used in simulations. In ref.29 and28, ∆α
has the value of -8.4 kBT and -6 kBT respectively, but
these values may be under-estimated since each α-mer is
assumed to still hold the same structure as before o mi-
cellation, and can only interact through one hydropho-
bic patch on the surface of the native monomeric state.
This scene is unrealistic because micellation usually un-
dergoes structural change to become a more stable state,
like collapsed amorphous micelles. On the other hand,
ref.71 does not have this pre-assumption and allows pep-
tides to reorganize its structure to form an amorphous
micelle. Even though it only models the peptides with
the core sequence that forms β-sheet in the aggregation
and may thus also undervalues ∆α term. Despite this
defect, we will use the values given in ref.71 to estimate
the value of ∆α. The bond interaction is approximately
-19.2 kcal/mol, which is taken from the amorphous dimer
case of Fig. 3 in ref.71. The free energy change due to
the entropic loss is evaluated as 9.2 kcal/mol under the
assumption that the peptide loses all its conformational
entropy upon bonding in the supplement of it. Together
with these two values, ∆α is roughly -17 kBT .
τI is the time-scale for internal α to β rearrangement
of amyloidogenic proteins, which cannot be theoretically
evaluated, as no simple theoretical models are proposed
to include internal friction in a dense protein structure.
Although τI for Aβ1−42 peptide is still unknown, it can be
approximated from the known value for insulin (in ref.55)
that has the closest protein length to Aβ1−42 peptide,
giving τI as 10
−5s.
For the ∆αβ value, although all-atomic simulations on
the free energy of one αβ bond in ref.29 was implemented,
it had the pre-assumption/constrains on the conforma-
tion of α-mers, not allowed to change from its native
monomeric structure in solution, and the resultant ∆αβ
value is doubtable to be used in the micelle model of
this work where α-mers within a micelle may not have
the same conformation as in the monomeric state. Un-
fortunately, no other specific experiments or all-atomic
molecular simulations considering this structural change
of monomers into a micelle have been conducted to de-
termine the value of this coupling energy.
We set the lower limit of ∆αβ by considering its role to
facilitate the conversion process. (5) can be used to ob-
tain the free energy change from an N -size micelle into
the conversion intermediate with only one α-mer con-
verted. If we first ignore the electrostatic and entropic
repulsion and focus on the role of the αβ bond free energy,
the result gives: ∆c+(∆αβ−∆α) [Nα(N)−Nα(N − 1)].
If ∆αβ equals to ∆α, it means that conversion of one
α-mer on the surface of an micelle or conversion of one
α-mer in solution are equally likely to happen because the
free energy change is the same, i.e. ∆c, in both cases. In
other words, micellation cannot help facilitate the con-
TABLE I. Summary of parameters. The values of bond ener-
gies are given in units of kBT at room temperature, with the
main reference to the source where available.
∆β ∆c ∆s µ
◦ ∆α ∆αβ τI
value -44 20 -22 -34.5 -17 -(17−23) 10−5 s
ref. 51 29 52 82 71 (see below) 55
version of α-mers and lower the free energy barrier along
the conversion process. The lower limit of ∆αβ is there-
fore set to be -18 kBT in our model, a little higher than
∆α. On the other hand, we consider the final conver-
sion step for intermediates with one α-mer left to fully
become the β-aggregate. This step gives the same free en-
ergy states involved in the elongation process: an α-mer
first attaches to the end of the pre-existing β-aggregate,
and then converts into the β-mer. The free energy of
the intermediate at x = N − 1 shall be higher than the
final free energy of the β -aggregate (x = N), so that
the final β-aggregate is more favored than partially con-
verted intermediates, and the elongation process will not
get thermodynamically trapped in the intermediate state.
We thus have the constraint on the upper limit of ∆αβ :
0 > ∆β + ∆s + ∆c − 2∆αβ . Therefore, ∆αβ should be
weaker than -23 kBT and has its lower limit of -17 kBT
as discussed earlier.
Appendix B: Derivation of k1
The shape of monomers can be approximated by a
sphere with the radius of 1 nm from the hydrodynamic
radius experiment of Aβ1−4283, while the trimer of the
paired protofilament (the critical nucleus in the NP mech-
anism) takes roughly the shape of a cuboid with dimen-
sions of 46A˚, 46A˚ and 8.4A˚ based on the structure of a
single β-mer given in ref.84. In this scenario, it is clear
that the collision between monomers and the critical nu-
clei is the non-spherical case, and in fact, no theoretical
formula of the collision rate is available for such a com-
plicated shape. Yet, a convenient way to estimate this
structural effect is to approximate it as in the elongated
ellipsoid case, as illustrated in Fig. 11(a), where as long
as the center of mass of one monomer enters the surface
of this ellipsoid (with the trimer being its center), the
collision is considered effective.
In this case, the inverse of the time required for one
monomer to diffuse to or hit the surface of the trimer,
1/τD, is written as
58:
1
τD
=
4piDmC1Ax1
2
√
1− (Ax2/Ax1)2
pi/2− arctan [Ax2/Ax1 2
√
1− (Ax2/Ax1)2]
(B1)
Here, Ax1 and Ax2 are the major and minor semi-axes
of the ellipsoid, respectively. We further let Ax1 equal to
half the sum of the length of the trimer and the monomer
diameter, which is (46 + 20)/2 A˚ and refers to the case
where the monomer contacts the top surface of trimer.
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Similarly, Ax2 equals to half the sum of the heigh and the
monomer diameter, giving (8.4+20)/2 A˚ and correspond-
ing to the case of side attachment of one monomer to this
trimer. A comparison with the Smoluchowski equation
and (B1) gives the geometric factor fgeo used in obtaining
the k1 value as:
fgeo =
Ax1
2
√
1− (Ax2/Ax1)2
pi/2− arctan [Ax2/Ax1 2
√
1− (Ax2/Ax1)2]
(B2)
With Ax1 of 33 A˚ and Ax2 of 14.2 A˚, fgeo is estimated
roughly as 26.4 A˚.
The constant Dm is assumed to be roughly twice the
diffusion coefficient of the spherical monomer: although
we know that the trimer has a different volume, the
difference in the diffusion constant between it and the
monomer is minor – while no simple calculation for an ac-
curate mutual diffusion coefficient is available. From the
Stoke-Einstein equation, Dm is expressed in terms of the
monomer size r1 and solvent viscosity η as kBT/3piηr1.
Putting this relation and (B2) into (B1), we obtain:
1
τD
=
4kBTC1fgeo
3ηr1
(B3)
Since we take the rate of linear aggregation as the rate
of progressing from N = 3 to N = 4 (the process re-
peats with the same parameters further on, due to the
linear N -dependence of the free energy, Fig. 4). There-
fore, this rate is determined by the barrier to reach the
critical nucleation size N = 3 of a paired protofilament,
plus the small free energy barrier for monomer aggrega-
tion on regular filament elongation, see Fig. 11(b) and
the detailed simulations57. Putting (B3) into the (3) we
finally obtain (4).
Why do the filaments not effectively depolymerize, af-
ter reaching and exceeding the critical nucleus size? The
rate constant of depolymerization kd (that is, the tran-
sition from N = 4 back to N = 3) is controlled by the
activation energy Fβ,2(3) − Fβ,2(4) + ∆Fel and its ratio
to kp, the further polymerization rate constant, is pro-
portional to the exponential factor
kd
kp
∝ exp
(
−Fβ,2(3)− Fβ,2(4)
kBT
)
≈ exp (−11.5− lnC1) ,
(B4)
using the (2) with N ≥ 3, and the values of energy pa-
rameters in Table 1. At the lowest limit of our examined
concentrations, lnC1 = −6.5 and the ratio of reverse-
forward rates is ∝ exp−5: even this upper bound is low
enough to consider only the forward rate of filament poly-
merization.
Appendix C: Derivation of k2
We consider a system of only three states: Smono,
monomers, Sint, the intermediate species, and Saggr, the
final β-aggregate. This system can go from Smono to Sint
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FIG. 11. (a) Sketch of the non-spherical shape of the trimer
nucleus, with the semi-axes Ax1 = (2.3 + 1) nm, and Ax2 =
(0.42 + 1) nm, defined following the notations of58. (b) A
sketch of a fragment of the free energy Fβ,2(N) illustrating
the additional (small) free energy barriers between the con-
secutive states of an elongating filament pair57.
with the micellation rate constant (k+), Sint to Saggr with
the conversion rate constant (kc), Sint to Smono with the
dissociation rate constant (k−). At Sint, the system can
either dissociate back into monomers or fully convert into
the β-aggregate. The inverse conversion from Saggr is not
considered based on the fact that the elongation rate of
any β-aggregate that exceeds the critical nucleus size is
rather fast, leaving almost no chance to reverse the ag-
gregation. The set of kinetic equations for each state are
written as:
dC1
dt
= k−Cint − k+C1
dCint
dt
= −(k− + kc)Cint + k+C1
dCaggr
dt
= kcCint (C1)
, where C1, Cint and Caggr are defined as the concentra-
tions of the Smono (monomers), Sint (intermediate) and
Saggr (the final β-aggregate) states, respectively. Our
aim is to find the average time for the system to first
reach the final state Saggr considering all the possible
paths. That is to find the average nucleation rate con-
stant k2 defined below :
dCaggr
dt
= k2C1 (C2)
All the rate constants defined in Eqs. C1 and C2 have
the dimension of the inverse of time, which then can be
used to find the time scale involved in this nucleation
process. The time required to travel from Smono to Sint
is defined as τ+, which is simply 1/k+. Similarly, τ−, the
time from Sint to Smono, is 1/k−, while τc, the time from
Sint to Saggr, equals to 1/kc.
To find the average time for nucleation, we need to find
out the time required for each path. For example, the
first path is Smono → Sint → Saggr and the second path
corresponds to Smono → Sint → Smono → Sint → Saggr.
All other paths will have more than two times of dissoci-
ating back and associating into a micelle again. For the
first path, the total travel time is (τ+ + τc), whereas the
second path requires [(τ+ +τ−)+1∗ (τ+ +τc)]. A general
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form for the travel time of the (n+ 1)th path, i.e. τn+1,
shall be
τn+1 = (τ+ + τ−) + n(τ+ + τc) (C3)
In this system, only at Sint the decision is made to
fully convert to the aggregate or to dissociate back into
monomers. The probability to convert is denoted as Pc,
which is proportional to kc, while the probability to dis-
sociate back is P− and is proportional to k−. We then
have the normalized probability of conversion and disso-
ciation:
Pc =
kc
kc + k−
; P− =
k−
kc + k−
(C4)
For the (n+ 1)th path, the system needs to dissociate
back n times and finally a conversion follows, and the
probability for this to happen, Pn+1, is readily written
as
Pn+1 = P
n
−Pc (C5)
The average time to reach Saggr, denoted as τave, is the
summation of products of the time required for different
paths and their probability to happen:
τave = Σ
∞
0 τn+1Pn+1 (C6)
Inserting Eqs. C3, C4 and C5 into (C6) and taking the
inverse of it, we arrive at the formula of (7).
Appendix D: Derivation of k+
The rate collisions between a monomer and a mi-
celle of size (N − 1) is expressed by the Smoluchowski
relation using the mutual diffusion coefficient Dm =
D1 + DN−1: 4piDm(r1 + rN−1)C1CN−1. Here r1 is the
radius of a monomer, while rN−1 is the radius of an
(N − 1)-size micelle. CN−1 is the concentration of the
(N − 1)-size micelle, which is between the Nh and Nl
size in the three-state kinetic model (in order to have a
metastable/intermediate state). This rate, by definition,
is equal to k+C1, which is how we shall determine this
rate constant.
Due to the micellation free energy barrier for
monomers to cross to aggregate into this (N − 1)-size
micelle, we assume a pre-thermal equilibrium for the con-
centrations of the micelles whose size is smaller than Nh,
the micelle size that gives the micellation free energy bar-
rier. Accordingly, we can easily write the CNh term as:
CNh = C1e
−∆Fmic
kBT , (D1)
where ∆Fmic refers to the micellation free energy and is
simply (5) at N = Nh.
In order for this Nh-size micelle to aggregate into
(N − 1)-size, it has to adsorb additional (N − Nh − 1)
monomers. We may further assume that this Nh-size
micelle acts as a deep absorbing sink. Monomers are
adsorbed as soon as they contact the surface of the
Nh-size micelle, which requires that the center of mass
of one monomer to fall inside the spherical volume of
4pi (rNh + r1)
3
/3, a region that is bound by the radii of
one monomer and the pre-existing micelle ofNh size. The
volume conservation is implemented to estimate rNh as
r1
3
√
Nh. In this way, the probability of adsorption of n
monomers to this pre-micelle, Pa,n, is:
Pads,n =
[
4pir31
(
1 + 3
√
Nh
)3
C1/3
]n
(D2)
With (D1) and (D2), CN−1 is given as
CN−1 =Pads,N−Nh−1CNh (D3)
=
[
4
3
pir31(1 +
3
√
Nh)
3
]N−Nh−1
e−∆Fmic/kBTCN−Nh1 .
For the estimation of the mutual diffusion coefficient
Dm, the Stokes-Einstein equation is used to express Dm
in terms of the viscosity of solvents η, temperature T and
the size of the micelle and monomer. Together with the
rN−1 expressed in r1, it gives:
Dm = D1 +DN−1 =
kBT
6piηr1
(
1 +
1
3
√
N − 1
)
. (D4)
Inserting (D1) and (D3) into 4piDmCN−1, we obtain
k+ as written in (8).
